The role of p53 in glioma progression is an ongoing discussion, with a working hypothesis that the over-expression of mutated p53 may mark a more aggressive tumor biology and that TP53 mutations may participate in progression from low-grade to a higher grade lesion [19]. The gene discussed is TP53; the disease is central nervous system cancer.